Blog

Credibly reintermediate backend ideas for cross-platform models. Continually reintermediate integrated processes through technically sound intellectual capital.
certificado_Cat-1200x674.jpg

¡Buenas noticias para Bogotá y toda Colombia! El Banco Distrital de Sangre del IDCBIS ha obtenido la certificación más prestigiosa en calidad para los bancos de sangre a nivel internacional. La Fundación CAT, reconocida entidad de certificación en transfusión, terapia celular y tisular de España, ha otorgado a esta institución de salud una acreditación que garantiza la excelencia en sus prestaciones médicas.

Este logro trascendental coloca al Banco Distrital de Sangre IDCBIS en un lugar destacado no solo a nivel nacional, sino también como referente internacional en bancos de sangre y servicios de transfusión. Nuestra entidad ha demostrado su compromiso inquebrantable con la calidad y la seguridad al ser el único banco en el país que realiza pruebas de biología molecular (NAT) al 100% de los componentes sanguíneos para garantizar la seguridad en las transfusiones.

La acreditación CAT, que se renueva cada cuatro años, destaca la excelencia en medicina transfusional que el Banco Distrital de Sangre IDCBIS ofrece a la sociedad. Tanto los donantes como los pacientes que reciben los hemocomponentes de este banco se benefician de la seguridad y calidad garantizada por esta certificación.

El Dr. Bernardo Camacho, director del IDCBIS, expresó su satisfacción al recibir la noticia: “Nos complace anunciar a la comunidad científica, académica, sanitaria y a la sociedad, la obtención de esta certificación internacional en calidad para nuestro Banco Distrital de Sangre. Cumplimos con los más altos estándares de calidad europeos en la captación, procesamiento y distribución de los hemocomponentes”.

Esta certificación no solo enaltece al Banco Distrital de Sangre IDCBIS, sino que también posiciona a Bogotá como un referente en calidad en medicina transfusional, generando reconocimiento y confianza en los productos y servicios de salud ofrecidos a la población. El compromiso de nuestra institución con la seguridad y calidad de las donaciones es evidente en sus estrictos protocolos y estándares internacionales, lo que garantiza que cada donante experimente un proceso seguro y cómodo.

Le puede interesar: Una donación, cuatro bebés beneficiados

Con este logro, los pacientes que dependen de transfusiones sanguíneas pueden tener la tranquilidad de recibir componentes de la más alta calidad y seguridad.

En resumen, el Banco Distrital de Sangre IDCBIS ha alcanzado un hito excepcional al obtener la certificación CAT, consolidando su liderazgo en la medicina transfusional y proyectando a Bogotá como una ciudad comprometida con la excelencia en el cuidado de la salud de sus ciudadanos. Esta noticia nos llena de orgullo y confianza en el sistema de salud de nuestra ciudad y país.

¡Felicidades al Banco Distrital de Sangre IDCBIS por este logro sobresaliente en beneficio de toda la comunidad!

 


a1.png

The institute has been recognized for meeting very strict criteria, as well as for its advances in research.

Note originally published in: ediciónmedica.com

The District Institute of Science, Biotechnology and Innovation in Health (IDCBIS), has informed the entire community, both scientific and academic, that the Transfusion, Tissue and Cellular Medicine Research Group (GIMTTYC) has obtained the classification of "Transfusion, Tissue and Cellular Medicine" group. A1 research by the Ministry of Science, Technology and Innovation.

It should be noted that the group GIMTTYC is an interdisciplinary group with actions aimed at the development of three main areas in health: transfusion medicine, tissue and cellular therapy.

Its objective has been to identify health problems in the areas of transfusion medicine, tissue and cellular therapy in order to contribute in the solution through the development of research projects based on ethical criteria, that generate new knowledge, strengthen the training of researchers and consolidate research networks.

In interview with MEDICAL EDITION, Bernardo Camacho, director of the IDCBIS, said that "in the last call for applications more than 7,000 research groupsThe application is very rigorous, but in the end, a small group obtained the recognition, 849 groups remained".

Camacho explained that, "in group A there are 1,174, in group B there are 1,830 and in group C there are 2,376 groups. The A group has the least number of groups, but there are still 531 recognized groups."He added that "the A1 group is for research, which is like the top, in the sense that it is required to rigorously comply with the criteria to be in this group".

"In our case for the last four years we were in group C, but now we go up to A1 this is due to several factors, firstly having a senior researcher, international, scientific publications in high impact indexed journals," Camacho pointed out.

"For us that was very important because we were recognized in the field of health sciences, but we specifically have a research focus in the area of advanced cell therapies, among others. So we were recognized because we have carried out a great deal of scientific research and even original research in the focus that we have," said Camacho.

The director also explained that they train master's and doctoral students, and also have associate and senior researchers. "We are implementing the inclusion of more senior researchers."

"That designation is earned by all the achievements that the research group has made, but in October of the previous year we were recognized as a research center for the next five years, this due to the strength in information and scientific production, which performs the team of scientists who are working with us," Camacho has pointed out.

 


Líder-unidad-de-inmunohematología-avanzada-1200x563.jpg

The ISBT Working Party on Rare Donors is a prestigious global community with members in more than 18 countries.

Paula Andrea Gaviria, Leader of the Advanced Immunohematology Unit of IDCBIS, was selected by the "International Society of Blood Transfusion (ISBT)" as the most recent member of the "ISBT Working Party on Rare Donors", being the first Colombian and the third Latin American to achieve it. 

The ISBT Working Party on Rare Donors aims to "provide a mechanism for collaboration between countries to enable the provision of rare blood products to patients in need".

According to the International Society of Blood Transfusion (ISBT), the group to which the IDCBIS collaborator now belongs is "a community eager to ensure that every patient who needs rare blood can receive it. This activity recognizes no political boundaries and is therefore all for the common good of patients all over the world".

The other two Latin American members of this group are Brazilian doctors Lilian Castilho and Silvano Wendel.


premio-mintic-para-IDCBIS-1200x600.jpeg

12 November, 2021 InvestigationNewsAwards

With this recognition, IDCBIS consolidates its position as the main actor in science and technology in the District and a reference for the country and the region.

September 10, 2021. Under resolution 1763 of 2021, the Ministry of Science, Technology and Innovation recognized the District Institute of Science Biotechnology and Innovation in Health (IDCBIS) as a research center for 5 years, a recognition that the Institute had received in 2019 for a period of one year.

In the resolution, the Ministry states the reasons why the IDCBIS is worthy of the designation, among them "high commitment to the development and implementation of strategies that are linked to the development of the country, articulated with the research policy from the research, training, technology transfer and generation of new knowledge axes.”.

According to IDCBIS director, Dr. Bernardo Camacho, "This recognition is the result of a work that began to take shape 20 years ago with the creation of the District Hemocenter and that four years ago materialized with the creation of the IDCBIS, joining the efforts of the Blood Bank, Tissue Bank and Cord Blood Bank with research and development of products in transfusion, tissue and cellular medicine, promoting the generation of knowledge and innovation in biomedical sciences through the articulation of actors in science and technology".

The analysis carried out by the technical area of the Knowledge Generation Directorate of the Ministry of Science corroborated that the Institute "...has the capacity to generate and manage the knowledge of the Ministry of Science...".demonstrates proper planning in research, administrative, service delivery, management and financial activities”.

On the other hand, it is noted that there were "a significant increase in the number of researchers linked to the center with respect to the first evaluation, which will result in scientific production, technological processes and contribute to the formation of new human capital.”.

Finally, MinCiencias evidenced IDCBIS's capacity to generate high impact products, relevant to the scientific and academic society, and to society in general. "The entire infrastructure and scientific capabilities of the Institute are at the service of the city and the country, which will allow the creation of new alliances that are in line with the District's Development Plan."explained Dr. Bernardo Camacho.


reconocimiento-a-la-investigacion-cientifica-del-idcbis.jpg

7 September, 2020 NewsAwards

IDCBIS will be presenting the Abstract "Tissue Engineered Constructs Based on Mesenchymal Stromal Cells and Acellular Dermis induce the Release of Repair Factors for Cutaneous Lesions "at the 5th World Congress of the Tissue Engineering and Regenerative Medicine in Tokyo -Japan #Termis2018. This is a great recognition to the research work of Dr. Gustavo Salguero, Dr. Ingrid Silva and the entire team of the Advanced Therapies Unit.


el-banco-distrital-de-tejidos-idcbis-recibe-la-orden-civil-al-merito-1200x600.jpg

7 September, 2020 NewsAwards

The District Health Secretariat and the Council of Bogota awarded the order 'Social Responsibility Donate Bogota', to natural and legal persons committed to the donation of human organs and tissues in the Capital District.

The District Tissue Bank IDCBIS was awarded second place in Category 2: Promotion of donation for transplant purposes.

Likewise, the District Health Secretariat and the Council of Bogota made a special recognition to the institutions: Corporación Banco de Ojos de Colombia (Cobancol), Fundación Cosme y Damián and the Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud (IDCBIS), for their contribution in the promotion and operational management of organ and tissue donation for transplantation purposes, in 2017.

For 9 years, this initiative has recognized and honored people who encourage and promote, through awareness-raising activities, the donation of organs and tissues for transplant and implant purposes, and who support transplant patients.

During the first quarter of 2018, the District Health Secretariat managed the donation of 81 organs, corresponding to cadaveric donors (57 kidneys, 18 livers and 6 hearts), with which an equal number of patients were transplanted. Likewise, 31 living donor transplants were performed (21 kidneys and 10 livers).

The District Health Secretariat also reported that so far this year it has received 7 organs (4 kidneys and 3 livers) for transplant from other regions of the country, for a total of 83 beneficiaries.

IDCBIS, passion for science and life.


maryuris.jpg

27 September, 2019 NewsAwards

A few months ago, during her time at IDCBIS, Yurani, the mother of Maryuris, a girl whose life was saved by a blood-forming cell transplant two years ago, pre-registered for DarCélulas.

Maryuris and Yurani were interviewed by the media, as more than 20 umbilical cord blood units - processed at the IDCBIS Public Cord Blood Bank - have been transplanted. They gave testimony of a successful transplant.

Maternal umbilical cord blood contains cells capable of producing blood components, these are called hematopoietic progenitor cells, which, when transplanted into a patient with a serious blood disease, can generate new blood components. A process similar to sowing a seed capable of creating new plants.

Maryuris recovered from medullary aplasia, a disease in which the bone marrow stops producing the different blood components. Thanks to an umbilical cord blood cell transplant performed in Bogota in 2017.

Mayuris can now do her favorite activities such as skateboarding. It was all possible thanks to an altruistic donation of umbilical cord cells, which were processed and stored at the IDCBIS Public Cord Blood Bank.

Yurani expressed her willingness to be a blood-forming cell donor, pre-registering with DarCélulas at www.idcbis.org.co/darcelulas because she hopes, at some point, to be able to help someone who is in a similar situation to the one her daughter experienced a few years ago.


idcbis-entrega-reconocimiento-a-iglesia-cristiana-el-lugar-1200x600.jpg

12 March, 2019 NewsAwards

This Tuesday, the District Institute of Science, Biotechnology and Innovation in Health IDCBIS, belonging to the Health Sector, gave the Christian Church El Lugar de su Presencia recognition for its great support to blood donation from its community, with a total of 2753 blood donations in 22 donation days in recent years; this large number of altruistic acts has benefited more than 7,000 patients of the Public Hospital Network in the city of Bogota and other hospital institutions nationwide.

The award was presented by IDCBIS Director Dr. Bernardo Camacho to Pastors Claudia Bermúdez and Orlando Reyes and to representatives Alex Torres and Óscar Ferro, from El Lugar de su Presencia Church, who expressed their gratitude for being able to make these alliances with the Health Sector for the health and wellbeing of the capital's community.


idcbis-ha-sido-elegido-con-alto-puntaje-por-parte-del-comite-evaluador.png

12 October, 2018 NewsAwards
The projects selected are:
1. Evaluation of the supporting capacity of mesenchymal stem cells from different tissues in the expansion of cord blood hematopoietic progenitor cells. Investigator: Dr. Ximena Bonilla 
 
2. Design and evaluation of skin substitutes generated from biological scaffolds and Wharton's Jelly mesenchymal stromal cells for the repair of chronic skin ulcers.Investigator: Dr. Ingrid Silva


Logo a color IDCBIS Centro de investigación reconocido por minciencias r-1763-2021

PASIÓN POR LA CIENCIA Y LA VIDA



en_USEnglish
Skip to content